Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 5
Submit an article Journal homepage
500
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Development and validation of the AML-QOL: a quality of life instrument for patients with acute myeloid leukemia

Sarah A. BuckleyDivisions of Clinical Research, University of Washington, Seattle, WA, USA; ;Fred Hutchinson Cancer Research Center and Division of Medical Oncology, University of Washington, Seattle, WA, USA; Correspondence[email protected]
View further author information
,
Anna B. HalpernDivisions of Clinical Research, University of Washington, Seattle, WA, USA; ;Divisions of Hematology, University of Washington, Seattle, WA, USA; View further author information
,
Megan OthusPublic Health Sciences, University of Washington, Seattle, WA, USAView further author information
,
Diana Jimenez-SahagunDivisions of Clinical Research, University of Washington, Seattle, WA, USA; View further author information
,
Roland B. WalterDivisions of Clinical Research, University of Washington, Seattle, WA, USA; ;Fred Hutchinson Cancer Research Center and Division of Medical Oncology, University of Washington, Seattle, WA, USA; View further author information
&
Stephanie J. LeeDivisions of Clinical Research, University of Washington, Seattle, WA, USA; ;Fred Hutchinson Cancer Research Center and Division of Medical Oncology, University of Washington, Seattle, WA, USA; View further author information
Pages 1158-1167 | Received 04 Nov 2019, Accepted 15 Dec 2019, Published online: 07 Jan 2020

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Anna B. Halpern & Elihu H. Estey. (2022) More general incorporation of hemoglobin level into response criteria for myelodysplastic syndrome and acute myeloid leukemia with increase in minimum red cell transfusion levels. Leukemia & Lymphoma 63:3, pages 514-517.
Read now
Fabio Efficace, Laura Cannella, Massimo Breccia, Jacopo Olivieri, Uwe Platzbecker & Marco Vignetti. (2021) Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature review. Expert Review of Hematology 14:7, pages 645-654.
Read now

Articles from other publishers (8)

Ginna Granroth, Nandita Khera & Cecilia Arana Yi. (2022) Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults. Current Hematologic Malignancy Reports 17:6, pages 243-253.
Crossref
Michaela A. Dinan & Devon K. Check. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 13 .
Naseema Gangat & Ayalew Tefferi. (2022) To live is well but to live well is better: venetoclax combination therapy and quality-of-life in acute myeloid leukemia. Blood Cancer Journal 12:4.
Crossref
Keith W. Pratz, Panayiotis Panayiotidis, Christian Recher, Xudong Wei, Brian A. Jonas, Pau Montesinos, Vladimir Ivanov, Andre C. Schuh, Courtney D. DiNardo, Jan Novak, Vlatko Pejsa, Don Stevens, Su-Peng Yeh, Inho Kim, Mehmet Turgut, Nicola Fracchiolla, Kazuhito Yamamoto, Yishai Ofran, Andrew H. Wei, Cat N. Bui, Katy Benjamin, Rajesh Kamalakar, Jalaja Potluri, Wellington Mendes, Jacob Devine & Walter Fiedler. (2022) Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia. Blood Cancer Journal 12:4.
Crossref
Fabio Efficace, Uwe Platzbecker, Massimo Breccia, Francesco Cottone, Paola CarluccioPrassede SalutariEros Di BonaErika BorlenghiFrancesco Autore, Luciano Levato, Olimpia FinizioValentina ManciniStefano D’ArdiaRichard F. Schlenk, Lorella MelilloMonica Fumagalli, Walter FiedlerGermana BeltramiNicola Stefano FracchiollaMassimo Bernardi, Paola FaziOmbretta Annibali, Karin Mayer, Maria Teresa Voso & Marco Vignetti. (2021) Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy. Blood Advances 5:21, pages 4370-4379.
Crossref
Roland B. Walter & Elihu H. Estey. (2020) Selection of initial therapy for newly-diagnosed adult acute myeloid leukemia: Limitations of predictive models. Blood Reviews 44, pages 100679.
Crossref
Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else, Jonathan Kell, Adele K. Fielding, Daniel M. Jennings, Marina Karakantza, Saad Al-Ismail, Graham P. Collins, Stewart McConnell, Catherine Langton, Magda J. Al-Obaidi, Metod Oblak & Sam Salek. (2020) Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO. Frontiers in Pharmacology 11.
Crossref
Maribel Salas, Mackenzie Henderson, Angelika Wientzek-Fleischmann, Zahidul Islam, Nora Tu, Aikaterini Bilitou, Maggie Elsharkawy & Ulf Stellmacher. (2020) Validated Instruments of Quality of Life (QOL) in Patients With Acute Myeloid Leukemia (AML) and Other Cancers. Frontiers in Pharmacology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.